1. Pan, Jing-Hua, Zhou, Hong, Cooper, Laura, Pan, Yun-Long, Rong, Lijun. 2019. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers. In Frontiers in immunology, 10, 6. doi:10.3389/fimmu.2019.00006. https://pubmed.ncbi.nlm.nih.gov/30761122/
2. Xiao, Shuxiu, Lu, Lili, Lin, Zhiyuan, Wu, Weizhong, Zhou, Yuhong. 2024. LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8+ T Cell Function in Hepatocellular Carcinoma. In Journal of hepatocellular carcinoma, 11, 1031-1048. doi:10.2147/JHC.S464806. https://pubmed.ncbi.nlm.nih.gov/38859944/
3. Cao, Liangbin, Zhu, Lingling, Cheng, Li. 2022. ncRNA-Regulated LAYN Serves as a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Hepatocellular Carcinoma: A Bioinformatics Analysis. In BioMed research international, 2022, 5357114. doi:10.1155/2022/5357114. https://pubmed.ncbi.nlm.nih.gov/36398067/
4. Jiawen, Wang, Jinfu, Wang, Jianyong, Liu, Yaoguang, Zhang, Jianye, Wang. 2023. Comprehensive landscape of the miRNA-regulated prognostic marker LAYN with immune infiltration and stemness in pan-cancer. In Journal of cancer research and clinical oncology, 149, 10989-11011. doi:10.1007/s00432-023-04986-7. https://pubmed.ncbi.nlm.nih.gov/37335337/
5. Qiu, Xunan, Guo, Rui, Wang, Yingying, Wang, Bengang, Gong, Yuehua. 2024. Mendelian randomization reveals potential causal relationships between cellular senescence-related genes and multiple cancer risks. In Communications biology, 7, 1069. doi:10.1038/s42003-024-06755-9. https://pubmed.ncbi.nlm.nih.gov/39215079/